Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | BMP1 | P13497 | 2/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22469045 | 0.90 | CNR2 (0.64) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL6798304 | 0.86 | THRB (0.51) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL6804511 | 0.81 | ALDH1A1 (0.56) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL7093324 | 0.81 | TP53 (0.65) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL7000836 | 0.79 | BMP1 (0.69) | TP53ALDH1A1MAPTBMP1 | |
| SCHEMBL16793775 | 0.78 | TP53 (0.55) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL7886751 | 0.77 | BMP1 (0.58) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL22469193 | 0.77 | CNR2 (0.72) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL7063146 | 0.75 | STAT5B (0.47) | THRBTP53ALDH1A1MEN1KMT2A | |
| SCHEMBL6808058 | 0.75 | ALDH1A1 (0.53) | THRBTP53ALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | THE PROCTER & GAMBLE COMPANY | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167183-A1 | Phenethylamino sulfamic acids | PTPRM, PTPRS, PTPRE | THRB 2259/4885TP53 1609/4885ALDH1A1 622/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.